What Ascendis plans for its European campaign

Healthcare group CEO Karsten Wellner says acquisitions will be in higher-growth economies

Ascendis holds off on final dividend to focus on potential acquisitions

The healthcare group is looking to buy complementary businesses in 2018 with headline earnings up 91% in the year to June

Adcock Ingram to buy Genop Healthcare

Pharmaceutical company says the deal will allow it to diversify its product offering, as there is very little overlap between the two companies’ ...

Bophelo share up but still early days

The company still has much to prove before its liquidity levels showed up on the counter, says analyst

Innovations in oncology explode as new treatments gain approval

Novel cell therapies that reprogramme a body’s immune system to attack tumours are just now coming of age, but their developers are already bracing for ...

Discovery expects jump of up to 22% in HEPS and EPS

The main reason for the increase was that the previous year included one-off costs related to a UK acquisition and rebranding

Aspen earnings return to health

The pharmaceutical company says the boost in earnings per share was as a result of the once-off negative effect in the comparative period

Strategy ails Advanced Health as annual loss trebles

The after-tax loss was R48m, compared with R15.7m in 2016

Advanced Health warns of wider loss

The group has day-hospitals in SA and Australia, and says the losses are ‘as anticipated’

Roche cuts the price of breast cancer drug

The life-saving drug is not yet widely available to state patients but some healthcare facilities are buying it at a lower cost, says the Swiss pharma giant

Pfizer gets patent for pneumonia vaccine in India

The patent for Prevnar 13 allows Pfizer to sell it exclusively in India until 2026, which is a blow to poorer nations

Aspen hurt by ill winds lashing sector

Negative sentiment towards healthcare companies persists

What is hurting Advanced Health's growth plans?

The company, like the hospital industry, has been under pressure for some time

Time running out for medical-device licensing applications

About 100 manufacturers, importers and distributors have applied for licences ahead of the August 23 deadline

Medical schemes affected by dip in formal job sector

The group’s share price has plunged 22.45% in the past six months as fewer employed workers contribute to medical schemes

Members of liquidated Commed to be absorbed by Bonitas medical scheme

Bonitas has been chosen for Commed members to ensure their benefits are not compromised, Council for Medical Schemes registrar Sipho Kabane says

Need to stay informed?

Subscribe from R120 per month to get the best of Business Day, the Financial Mail, Business Times, RDM and more, along with perks such as exclusive Financial Times content.

Investors Monthly is a magazine published by Times Media, Media Division included in the Financial Mail on the last Thursday of the month.